Back
Inozyme Pharma Vs. Athira Pharma Industry Stock Comparison
Buy
62
INZY
Inozyme Pharma
Last Price:
4.64
Seasonality Move:
-8.94%
Sell
41
ATHA
Athira Pharma
Last Price:
2.15
Seasonality Move:
-38.28%
Buy
62
Inozyme Pharma (INZY)
is a Buy
Is Inozyme Pharma a Buy, Sell or Hold?
- The current Inozyme Pharma [INZY] share price is $4.64. The Score for INZY is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- INZY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Athira Pharma (ATHA)
is a Sell
Is Athira Pharma a Buy, Sell or Hold?
- The current Athira Pharma [ATHA] share price is $2.14. The Score for ATHA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ATHA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INZY Stock Price Chart
What is Inozyme Pharma's stock price today?
-
The Inozyme Pharma share price today is $4.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INZY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ATHA Stock Price Chart
What is Athira Pharma's stock price today?
-
The Athira Pharma share price today is $2.14
The current trend is relatively stagnant and ATHA is experiencing slight selling pressure.
INZY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 41.63 | Sell |
| Chaikin Money Flow: | 343053 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ATHA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 46.43 | Sell |
| Chaikin Money Flow: | -35262 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.94 - 2.38) | Sell |
| Bollinger Bands (100): | (2.18 - 3.42) | Sell |
INZY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.62 | Buy |
| 20-day SMA: | 4.63 | Buy |
| 50-day SMA: | 5.6 | Sell |
| 200-day SMA: | 4.66 | Sell |
| 8-day EMA: | 4.64 | Sell |
| 20-day EMA: | 4.83 | Sell |
| 50-day EMA: | 5.19 | Sell |
| 200-day EMA: | 4.9 | Sell |
ATHA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.02 | Buy |
| 20-day SMA: | 2.09 | Buy |
| 50-day SMA: | 2.58 | Sell |
| 200-day SMA: | 2.42 | Sell |
| 8-day EMA: | 2.06 | Buy |
| 20-day EMA: | 2.13 | Buy |
| 50-day EMA: | 2.42 | Sell |
| 200-day EMA: | 2.65 | Sell |
Inozyme Pharma Earnings Growth & INZY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.04 per share.
Athira Pharma Earnings Growth & ATHA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.46 per share, and a decrease next year of $0.00 per share.
Inozyme Pharma Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Athira Pharma Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||